LISTEN NOW: Decoding health outcomes at AMCP Annual Meeting 2025 - Prime Therapeutics
LISTEN NOW: Decoding health outcomes at AMCP Annual Meeting 2025
Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings
From March 31–April 3, thousands of managed care pharmacy and health care industry professionals gathered at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, where Prime Therapeutics (Prime) presented seven research posters and additional educational sessions that featured the latest research insights from medical and pharmacy claims data.
For the second consecutive year, Prime also tapped clinical and health outcomes experts for a special “on the road” episode of the Pharmacy Friends podcast. In this episode, hosted by Senior Public Relations Manager Alex Cook, hear more about the real-world impact of glucagon-like peptide-1 (GLP-1) receptor agonist medications, understand how predictive models can help identify members enrolled in Medicare Part D at risk of large increases in drug spend, the research that received the Journal of Managed Care & Specialty Pharmacy (JMCP)’s “Article of the Year” Award for Excellence, and other trends that shape the health care industry. This episode is a follow-up to an earlier episode of the podcast, which introduced listeners to the researchers at Prime and what inspires their work.
“So many people have come to us and recognize that our work is important,” said Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes. “We all learn together so that we can all try to improve how medications are used in the most affordable manner.”
Guests on this episode include:
- Connie Estep, PharmD, BCGP, senior specialty clinical solutions director, Prime
- Nick Friedlander, PharmD, senior health outcomes researcher, Prime
- Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes, Prime
- Almina Gomez, PharmD, resident, Prime
- YuQian Liu, PharmD, RPh, senior director of specialty clinical solutions and residency program director, Prime
- Katherine McKay, PharmD, resident, Prime
- Timothy O’Shea, PharmD, M.S., director of specialty pharmacy, Horizon Blue Cross and Blue Shield of New Jersey
- Rachael Prusi, PharmD, MSGH, senior specialty clinical solutions director, Prime
- Sneha Sharma, PharmD, senior specialty clinical solutions director, Prime
- Sean Shirk, PharmD, senior specialty clinical solutions director, Prime
- Ben Urick, PharmD, Ph.D., senior director of health outcomes, Prime
- Soumya Vishwanath, PharmD, formulary management director
Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming and, most importantly, what it means to you. Listen to the full episode “The research room: Decoding health outcomes (Part 2 – On the road at AMCP Annual)” on PrimeTherapeutics.com/Listen. 
Episode chapters
(01:05) 2024 JMCP “Article of the Year” Award for Excellence
(15:56) Accelerated Drug Approval Program
(28:00) PBM and Medical Pharmacy Industry Trends
(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering
(55:22) Legislative Impacts on Site of Service: What is the Big Deal?
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.